Vimpat (lacosamide): Reviews and patient testimonials
Medication indications
Vimpat 10 mg/ml solution for infusion
Vimpat is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
Vimpat 10mg/ml syrup
Vimpat is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
Vimpat 50mg, 100mg, 150mg and 200mg film-coated tablets
Vimpat is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
Route of administration: Injectable, Oral
Molecule: lacosamide
Patients' opinions on Vimpat
In brief
General satisfaction level: 3.50/10 Learn more
Treatment's effectiveness: 4.00/10 Learn more
Ease of use: 8.00/10 Learn more
Adherence to prescription: 8.00/10 Learn more
Detected side effects: 8.00/10 Learn more
Improvement in the quality of life: 8.00/10 Learn more
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community